Related Experiment Video
Updated: Feb 1, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Novel electrocardiographic features in carriers of hypertrophic cardiomyopathy causing sarcomeric mutations
Mikko Jalanko1, Tiina Heliö1, Pirjo Mustonen2
1Heart and Lung Center, Department of Cardiology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Insights
Novel electrocardiogram (ECG) parameters show promise in identifying hypertrophic cardiomyopathy (HCM) mutation carriers who do not yet have left ventricular hypertrophy (LVH). These new ECG findings could improve early detection and screening for HCM in families.
Area of Science:
- Cardiology
- Genetics
- Medical Diagnostics
Background:
- Conventional 12-lead ECG has limited sensitivity and specificity for detecting hypertrophic cardiomyopathy (HCM) mutation carriers without left ventricular hypertrophy (LVH).
- Early identification of HCM mutation carriers is crucial for timely intervention and management.
- Genetic predisposition plays a significant role in the development of HCM.
Purpose of the Study:
- To assess the ability of novel electrocardiographic parameters to improve the detection of HCM mutation carriers, particularly those without LVH.
- To introduce and evaluate new ECG variables: RV1
RV3 and septal remodeling. - To compare the diagnostic performance of novel ECG parameters against conventional criteria.
Main Methods:
- Study included 140 HCM mutation carriers (G+) and 30 controls.
- Carriers were divided into groups with (G+/LVH+) and without (G+/LVH-) left ventricular hypertrophy.
- Novel ECG parameters (RV1
RV3, septal remodeling) were analyzed alongside standard ECG criteria. Cardiac MRI and echocardiography were performed on a subset.
Main Results:
- Conventional ECG criteria were highly sensitive (90%) and specific (97%) for G+/LVH+ subjects.
- RV1
RV3 and septal remodeling were significantly more prevalent in G+/LVH- subjects than controls (p<0.005). - Combinations of novel parameters with Q waves and repolarization abnormalities (QR) achieved high specificity (97%) in differentiating G+/LVH- subjects from controls.
Conclusions:
- Novel ECG parameters, RV1
RV3 and septal remodeling, are effective in identifying HCM mutation carriers without LVH. - These novel ECG findings hold potential for improving diagnostics in suspected HCM cases.
- The parameters may also be valuable for screening and follow-up within HCM families.
Objectives:
The sensitivity and specificity of the conventional 12-lead ECG to identify carriers of hypertrophic cardiomyopathy (HCM) - causing mutations without left ventricular hypertrophy (LVH) has been limited. We assessed the ability of novel electrocardiographic parameters to improve the detection of HCM mutation carriers.
Methods:
We studied 140 carriers (G+) of the TPM1-Asp175Asn or MYBPC3-Gln1061X pathogenic variants for HCM: The G+/LVH+ group (n = 98) consisted of mutation carriers with LVH and the G+/LVH- group (n = 42) without LVH. The control group consisted of 30 subjects. The standard 12-lead ECG was comprehensively analyzed and two novel ECG variables were introduced: RV1
Results:
Conventional major ECG criteria were sensitive (90%) and specific (97%) in identifying G+/LVH+ subjects. RV1
Conclusions:
The novel ECG-parameters RV1
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
The Sarcomere
Each...
Electron Carriers
Over the many stages of cellular respiration, glucose breaks down into carbon dioxide and water. Electron carriers pick up electrons lost by glucose in these reactions, temporarily storing and releasing them into the electron...
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Cardiomyopathy II: Dilated Cardiomyopathy

